Delivery Order SPE2DB20D3103-SPE2DB23FN0C2
Award Date
4/6/23
Potential Completion Date
4/7/23
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,155.95 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the provision of EXFORGE 10-320 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of March 14, 2024 and is structured as a firm fixed-price delivery order. This award does not have a set-aside designation, indicating it was competitively bid. AmerisourceBergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,092.89, is for the supply of 4568185974 - EXFORGE 10-160 MG TABLET 30S, a medication used to treat high blood pressure. The award is a firm-fixed price contract with a period of performance through May 9, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,817.75 firm fixed price contract is for the delivery of EXFORGE 10-160 MG TABLET 30S, a brand name pharmaceutical product. The contract has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp is the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,504.44 firm-fixed-price contract is for the delivery of EXFORGE 10-320 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of October 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $3,419.41 by the Defense Logistics Agency (DLA) to provide EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a completion date of January 26, 2024. This award is part of Amerisourcebergen Drug Corp's broader role as the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a firm fixed price ceiling value of $5,432.81 and a performance period ending on May 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,166.39 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EXFORGE 5-160 MG TABLET 30S pharmaceuticals. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of EXFORGE 10-320 MG TABLET 30S. The $3,517.59 firm-fixed-price contract has a completion date of July 30, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a wide range of medical commodities to support military treatment...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of EXFORGE 5-160 MG TABLET 30S, a prescription pharmaceutical product. The firm fixed price award, valued at $7,090.57, has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor, and this award is associated with a larger indefinite delivery contract (IDC) awarded by DLA with a potential...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,523.65 firm fixed price delivery order is for the supply of EXFORGE 10-320 MG TABLET 30S, a cardiovascular medication. The award is not associated with a set-aside program and has an ultimate completion date of December 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...